45.7
Novartis AG Sponsored ADR
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
Assets
(positive)
Change from FY21 to FY25
billions USD
FY21:
FY22:
36.9
FY23:
30.5
FY24:
29.7
FY25:
30.5
(positive)
Change from FY21 to FY25
billions USD
FY21:
86.1
FY22:
80.5
FY23:
69.5
FY24:
72.5
FY25:
80.5
Total assets
Change from FY21 to FY25
billions USD
FY21:
132
FY22:
117
FY23:
99.9
FY24:
102
FY25:
111
Liabilities & Equity
(negative)
Change from FY21 to FY25
billions USD
FY21:
30.2
FY22:
28.7
FY23:
26.4
FY24:
28.7
FY25:
27.3
(negative)
Change from FY21 to FY25
billions USD
FY21:
33.8
FY22:
29.4
FY23:
26.8
FY24:
29.4
FY25:
37.1
(positive)
Change from FY21 to FY25
billions USD
FY21:
67.8
FY22:
59.4
FY23:
46.8
FY24:
44.1
FY25:
46.5
Total liabilities & equity
Change from FY21 to FY25
billions USD
FY21:
132
FY22:
117
FY23:
99.9
FY24:
102
FY25:
111
All amounts in billions USD